Is Age ≥ 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study
- 30 May 2022
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 130, 105938
Abstract
No abstract availableKeywords
Funding Information
- Chongqing Medical University
- National Natural Science Foundation of China (81972460)
This publication has 25 references indexed in Scilit:
- Eliminating the Age Cutoff in Staging of Differentiated Thyroid Cancer: The Safest Road?The Journal of Clinical Endocrinology & Metabolism, 2018
- Controversial Issues in Thyroid Cancer ManagementJournal of Nuclear Medicine, 2018
- 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2)Endocrine-Related Cancer, 2018
- 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinomaCancer Biology & Medicine, 2017
- Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of OverdiagnosisNew England Journal of Medicine, 2016
- An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid CancerThyroid®, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid CancerAnnals of Surgical Oncology, 2015
- The Accuracy of Thyroid Nodule Ultrasound to Predict Thyroid Cancer: Systematic Review and Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2014
- The Implication of Lymph Node Metastasis on Survival in Patients with Well-Differentiated Thyroid CancerThe American Surgeon™, 2005